New guidelines in the treatment and prevention of osteoarticular diseases

Chronic skeletal diseases, among which the most common are osteoarthritis (arthrosis) and osteoporosis, are the biggest public health problem of our civilization. Despite this fact, confirmed by numerous statistics from the World Health Organization (WHT) and data that indicate that the complications of these diseases represent one of the greatest financial burdens of state economies, skeletal diseases have been ignored for many years and considered a consequence of normal aging.

THE USUAL HEALTH CLINICAL PRACTICE IS REDUCED TO PARTIAL AND SYMPTOMATIC THERAPY, WITHOUT A SATISFACTORY EFFECT FOR THE PATIENT

Therapy is predominantly still only partial and symptomatic. Prevention has not been and still is not given enough attention so far, and there has been a lack of significant interest from the profession in this area. In recent years, we have again witnessed the loss of interest of the public and the profession in issues related to difficult issues Osteoporosis. Consequently, we are witnessing this because of a certain disappointment with the effect of the drugs, as well as the realization that osteoporosis is a much more complex problem than previously thought, and which has resulted in reduced interest from the pharmaceutical industry. But all together, at the same time, is the result of a lack of basic knowledge about bones, both by doctors and by the population as a whole.

When it comes to Osteoarthritis, in fact, nothing much has changed there for years. It is still dominated by the opinion that nothing can be done anyway, we cannot regenerate cartilage so we have no choice but to temporarily reduce the discomfort with various methods of physical therapy, and in more severe cases to implant prostheses and artificial joints.

It is amazing how deeply rooted these attitudes are among the profession and doctors who find it difficult to accept new methods and insights. It is as if one does not want to admit that the approach to chronic diseases so far has been poor, flawed and inadequate.

IS IT REALLY NOT POSSIBLE TO BETTER TREAT PATIENTS SUFFERING FROM CHRONIC OSTEO-ARTICULAR DISEASES? YES, IT CAN.

How is it that in some other areas medicine has made great progress, and when it comes to skeletal diseases we are still tapping the spot?

A skeleton is not just a set or pile of bones and joints, but an indivisible whole that functions connected in a single harmonious relationship so that changes in one part of the skeleton are transmitted and reflected to the entire skeleton.

For example, osteoarthritis of the knee should not be considered only a disease of the knee. Osteoarthritis of the knee leads to a significant disturbance of the bio-mechanical balance and thus overload on other joints with the consequent development of osteoarthritis and other degenerative processes in these joints. For this reason, the eventual replacement of the knee with a prosthesis cannot solve the problem as a whole, e.g. it can eliminate pain in that knee, but also potentiate the development of similar problems in other parts of the skeleton, such as the spine or hips.

Less well known is that due to the disturbed bio-mechanical balance, as a result of osteoarthritis, bone quality also deteriorates, which increases the risk of fractures.

In such cases, the sum of the numerous calcifications that accompany osteoarthritis, we will often not find a low mineral density on bone densitometry and we will not recognize osteoporosis, although this is precisely what it is about.

After all, it is well known that in almost 50% of cases of fractures to minor trauma, which is a sure sign of poorer bone strength, therefore osteoporosis, a normal finding of bone densitometry is found.

WHY DO WE NEED A NEW CONCEPT OF TREATMENT AND WHAT IS IT BASED ON?

Based on scientific studies and clinical experience, we can say the following:

• The skeleton is a unique organ, consisting of a lot of bones and joints and at least three types of tissue: bone, cartilage and muscular-connective.
• The skeleton is influenced by numerous factors that we can divide into genetic, bio-mechanical and metabolic or bio-chemical. Because bone structure is constantly changing through the continuous process of bone remodeling, the structure and quality of bone is the result of the simultaneous action of all these factors.
• The function of the skeleton depends on the structure and quality of all its parts, and therefore it is always necessary to carry out an integral treatment of the skeleton as a whole.
• Diagnostic procedures and imaging can not accurately determine the state of the skeleton, so it is necessary to assess the condition using a combination of several methods, predict risks and dynamics, and plan therapy based on this. Therefore, a good knowledge of the biology of the skeleton and the possibilities of the individual diagnostic and therapeutic methods is essential, which is why the education of doctors in this area, which is sometimes deficient, should be improved.
• Since it is not possible to act on all parts of the skeleton with the same therapeutic agent or drug, the treatment must necessarily be carried out in a complementary way, with a combination of several methods.

WHAT SHOULD MEET THE NEW TREATMENT CONCEPT?

Thus, there is too much evidence to lead to the conclusion that we need to change something in the approach to chronic osteo-articular diseases. Fortunately, in recent years, spurred by increasing industry interest and better funding, great progress has been made in the knowledge of skeletal biology and significantly increased treatment options through the introduction of new drugs and technologies. Now it is the turn of clinicians and society as a whole to translate these new scientific insights and technological capabilities into clinical practice.

MBST® - Therapeutic Magnetic Resonance

Nuclear magnetic resonance imaging (NMR, MRI or MR) marked a revolution in diagnostics just over forty years ago. It provided a hitherto unthinkable representation of the internal structures of the body. It is now also available as a method of prevention and treatment of osteoporosis and osteoarthritis through the application of the MBST® method, designed and patented in Germany in cooperation with leading research institutes and universities.

By regularly conducting a cycle of therapeutic magnetic resonance therapy for osteoporosis, lasting 10 days, selective cell therapy stimulates the formation of a new bone matrix and thus strengthens the innate properties of bone flexibility and strength.

MBST has also been shown to promote cartilage repair and play a major role in the successful treatment and prevention of osteoarthritis in the joints and spine. The use of MBST as monotherapy or in combination with other complementary methods, depending on the individualized assessment of the status of each patient, provides optimal treatment value.